DCVC Bio — Full Portfolio

Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.

BiotechHealthtechSeattle, US

AMAndrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)Andrew Scharenberg(Founder)Michael Jensen(Founder)Philip Low(Founder)Ryan Crisman(Founder)

Board seatJohn Hamer· per SEC Form D

Co-investorsMPMPM BioImpactQIQiming Venture Partners USASOSoftBank GroupK2K2 HealthVenturesSOSoftBank Vision FundALAlexandria+2 more

Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.

AI & Machine LearningBiotechDeep TechHealthtech

JOJane Osbourn(Founder)Young Kwon(Founder)

Co-investorsRARA CapitalSVSV Health InvestorsDEDementia Discovery FundLILightstone VenturesONOno Venture Investment, Inc.BRBritish Business Bank+3 more

Empirico is a clinical-stage biotechnology company that pairs human genetics-driven target discovery with siRNA medicine development to create genetic medicines for common diseases with unmet need.

AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US

Omri Gottesman(Co-Founder; Chief Executive Officer and President)Shannon Bruse(Co-Founder; SVP, Head of Target Discovery and Biology)Brian Cajes(Co-Founder; SVP, Head of Data Platforms and Engineering)Bill McLeod(Chief Financial Officer)Michael Molyneaux(Chief Medical Officer)David Lewis(SVP, Head of Drug Discovery and Development)

Co-investorsNENeotribe VenturesQIQiming Venture Partners

Fable Therapeutics is a biotech company using protein engineering to develop biologics targeting the activin receptor type II (ActR2) pathway for obesity and related metabolic diseases.

BiotechHealthtechLongevity

GMGeoff MacKay(President & CEO)David Baker(Chief Scientific Officer)Rhonda Wideman(Chief Business Officer)Zack McNealy(Chief Financial Officer)

Co-investorsMPMPM BioImpactVEVersant VenturesLILilly Asia VenturesDCDCVC (Data Collective)

BioCentury provides news, analysis, and data covering the biotechnology and pharmaceutical industries.

BiotechData & InfrastructureEnterprise SoftwareMedia & EntertainmentDurham, US

Pieter Burger(Executive Officer, Director)inTKThomas Kaiser(Executive Officer, Director)in

BoardCMChristopher Meldrum(Executive Officer, Director)inDennis Langer(Director)

Board seatJohn Hamer· per SEC Form D

Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods.

AgTechBiotechClimate TechFoodTechNew MaterialsDurham, US

ToddMFMichele Fite(Executive Officer)inMTMatthew Todd Rands(Executive Officer, Director)CPChloe Pavely(Executive Officer)inMDMatt DiLeo(Director)inPBPaul Boyer(Executive Officer)in

Board seatKiersten Stead· per SEC Form D

Co-investorsDCDCVC (Data Collective)ACAccelr8KDKdT VenturesNONovo Holdings

Empirico is a San Diego-based clinical-stage biotech that uses human genetics data and computational methods to discover disease targets and develop siRNA and antibody therapeutics.

BiotechSan Diego, US

Omri Gottesman(Executive Officer, Director)inShannon Bruse(Executive Officer, Director)inBrian Cajes(Executive Officer)in

BoardKolluri Swaroop(Director)

Board seatJohn Hamer· per SEC Form D · $55.2M raise · filed Mar 2023

Co-investorsDCDCVC (Data Collective)FEFelicis VenturesQIQiming Venture Partners USAQIQiming Venture Partners

MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.

BiotechCircular EconomyNew MaterialsEmeryville, US

Philip Ross(Founder)inMichael Lindheim(Executive Officer)MSMatthew Scullin(Executive Officer, Director)inEddie Pavlu(Founder)Phil Ross(Founder)Sophia Wang(Founder)

Board seatKiersten Stead· per SEC Form D

Co-investorsATATEL VenturesDCDCVC (Data Collective)GAGaingelsHEHemisphere Ventures LLCSOSOSVVAValor Equity Partners+9 more

Unlearn develops AI-powered digital twins and data analytics tools to optimize clinical trial design and execution for pharmaceutical companies.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSan Francisco, US

CFCharles Fisher(Founder)inASAaron Smith(Founder)inJonathan Walsh(Founder)John Hamer(Director)Francisco Gimenez(Director)

Board seatJohn Hamer· per SEC Form D

Co-investors8V8VCALAlumni VenturesBABasecamp FundDCDCVC (Data Collective)EIEisai Innovation, Inc.FLFlucas Ventures+6 more

AgZen develops real-time monitoring technology for crop spraying, analyzing droplet behavior to help growers and agricultural equipment manufacturers optimize application efficiency.

AgTechAI & Machine LearningFintechHardwareImpact & Social GoodMedia & EntertainmentSomerville, US

VJVishnu Jayaprakash(Founder)inKVKripa Varanasi(Director)inMDMaher Damak

BoardCarmichael S. Roberts(Director)Justin Kern(Director)

Co-investorsASAstanor VenturesMAMaterial ImpactDCDCVC (Data Collective)SYSyngenta Group Ventures

BiotechNewton, US

Katharine Yen(Executive Officer, Director)KYKate Yen(Founder)inChristopher Guiffre(Executive Officer)

BoardAlon Lazarus(Director)AFAnna French(Director)inACAlexandra Cantley(Director)in

Co-investorsDCDCVC (Data Collective)QIQiming Venture Partners USAAPApollo Health VenturesBRBrightEdgePOPolaris PartnersQIQiming Venture Partners

CH4 Global develops greenhouse gas mitigation solutions centered on Asparagopsis seaweed, producing feed supplements that reduce enteric methane emissions from cattle for the livestock and agriculture industries.

AgTechCleantechClimate TechFoodTech

SMSteve Meller(CEO, President & Co-Founder)in

Co-investorsCLCleveland AvenueDCDCVC (Data Collective)NENextwave [X] PartnersAGAgFunder

Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides.

AI & Machine LearningBiotechDeep Tech

MLMatthew Levy(Co-founder)in

Co-investorsLULux CapitalTETenmile

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsBIBioBritDCDCVC (Data Collective)TETenmileALAlexandriaCACasdin CapitalLULux Capital

DCVC is a deep technology venture capital firm that invests in entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, robotics, space, biology, and defense.

AI & Machine LearningClimate TechDeep Tech

MOMatt Ocko(Founder and Managing Partner)inZBZachary Bogue(Founder and Managing Partner)DJDr. John Hamer(Co-founder and Managing Partner, DCVC Bio)Dr. Kiersten Stead(Co-founder and Managing Partner, DCVC Bio)

Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome.

AI & Machine LearningBiotechSouth San Francisco, US

CVChris Varma, Ph.D.(Executive Officer, Director)CVChris Varma(Co-founder, Chairman and CEO)inJim Winkler(Executive Officer)JHJohannes Hermann, Ph.D.(Executive Officer)KWKevin Webster(Executive Officer)inGregory Chow(Executive Officer)

Co-investorsBEBerkeley CatalystDCDCVC (Data Collective)DRDroia VenturesFEFelicis VenturesMPMPM BioImpactRARA Capital+2 more

Greater Long Island is a local news and media outlet publishing stories and coverage about Long Island communities.

Media & Entertainment

Grove Biopharma develops Bionic Biologics, a drug discovery platform combining AI-enabled molecular design, precision polymer chemistry, and experimental biology to target protein-protein interactions that are inaccessible to conventional therapeutics.

AI & Machine LearningBiotechDeep TechChicago, US

GDGeoffrey Duyk(CEO)in

Co-investorsDCDCVC (Data Collective)INInVivium CapitalPOPortal InnovationsDEDeepWork Capital

Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise.

AI & Machine LearningBiotechDeep TechHealthtechPhiladelphia, US

Co-investorsHAHatch BioFund8V8VCBIBioAdvanceDCDCVC (Data Collective)GAGaingelsKOKorea Development Bank+1 more

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.

BiotechDeep TechMedical DevicesBoston, US

LGLuke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)DLDavid Liu, PhD(Founder)ALAngelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)JWJonathan Weissman, PhD

Co-investorsATAtlas VentureNENewpath Partners5A5AM VenturesARARCH Venture PartnersDCDCVC (Data Collective)F-F-Prime Capital+11 more

BiotechBoston, US

David Donabedian(Executive Officer, Director)inRHRobert Hadfield(Executive Officer)inJMJohn McCabe(Executive Officer)in

BoardCWChristoph Westphal(Director)Ming Cheah(Director)inRCRaymond Camahort(Director)

Co-investorsDCDCVC (Data Collective)ARArkin CapitalLOLongwood FundNONovo Holdings

The New Yorker is a magazine and digital publication producing reporting, criticism, essays, fiction, and cultural commentary, along with puzzles, podcasts, and cartoons.

Media & Entertainment

Nilo Therapeutics develops immunomodulation therapies that target brain-body neural circuits controlling systemic inflammation, aiming to treat autoimmune and inflammatory diseases.

BiotechDeep TechHealthtechNew York, US

JGJeff Goater(Executive Officer, Director)inKim Seth(CEO)in

BoardTKTim Kutzkey(Executive Officer, Director, Promoter)in

Co-investorsDCDCVC (Data Collective)THThe Column GroupALAlexandriaLULux Capital

South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.

Daly City, US

Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)

BoardElizabeth Stanley(Director)

Co-investorsALAlta PartnersCECerity Partners VenturesCOColorcon Ventures5A5AM VenturesALAlexandriaDCDCVC (Data Collective)+2 more

Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands.

AI & Machine LearningBiotechDeep TechMedical DevicesSan Diego, US

BEBrett Ewald(Chief Operating Officer, Founding Member)inALAlyssa Levin(Chief Financial Officer)inPGPaul Grayson(Chief Executive Officer)in

Co-investors5A5AM VenturesFRFrazier Life Sciences

BiotechMenlo Park, US

BEBrett Ewald(Executive Officer)inUmesh Gangadharmath(Executive Officer)inIMIstvan Molnar(Executive Officer)inYunfei Zhu(Executive Officer)Ana Kusnetzow(Executive Officer)inScott Struthers(Director)

Co-investorsDCDCVC (Data Collective)FRFrazier Life Sciences5A5AM VenturesFRFrazier Healthcare PartnersWEWestlake Village BioPartners

Sabanto retrofits existing tractors with an aftermarket autonomy system so growers can run field operations without a driver.

Itasca, US

CRCraig Rupp(Founder, CEO)in

Co-investorsCACavallo VenturesCECerity Partners VenturesDCDCVC (Data Collective)FUFulcrum Global CapitalLELeaps by BayerTRTrimble Ventures+1 more

Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.

BiotechHealthtechMedical DevicesSan Diego, US

EMEric Murphy(Chief Executive Officer, Co-Founder, & Director)in

Co-investorsASAstellas Venture Management LLCDCDCVC (Data Collective)FRFrazier Life SciencesLOLongwood FundNONovartis Venture FundOROrbiMed+2 more

Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation.

BiotechDeep TechMedical DevicesChicago, US

Ryan Clarke(Co-Founder, Chief Scientific Officer)inNBNiko Balanis, PhD(Co-Founder, Chief Technology Officer)inBrad Merrill, PhD(Co-Founder, Head of Innovation)MMMatt MacDougall, MD, PhD(Scientific Cofounder, Immunology Physician, Stanford University)inPatrick Shaddow(Executive Officer, Director)John Craighead, PhD(Chief Executive Officer)

Co-investorsASAstellas Venture Management LLCDCDCVC (Data Collective)DRDraper AssociatesILIllumina VenturesLOLong GamePOPortal Innovations+1 more

Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Neil Dhawan, PhD(Co-Founder)NUNassim Usman, PhD(CEO and President)

Co-investorsDCDCVC (Data Collective)SOSocial Impact Capital

Transcripta Bio develops medicines for patients with serious diseases by mapping how molecules affect human cells at single-cell resolution.

AI & Machine LearningBiotechDeep Tech

Co-investorsBLBlueYard CapitalGAGaingelsJAJAZZ Venture PartnersARARCH Venture PartnersINInsight PartnersMAMayo Clinic Ventures

Verdant is a software platform that manages the full planning and permitting workflow for local government agencies, from resident inquiries through final commission votes.

AI & Machine LearningGovTechSan Francisco, US

ANAidan Ng(Founder)inJYJason Yi(Founder)in

Co-investorsY Y CombinatorAGAgFunderAUAutotech VenturesCACavallo VenturesCLCleveland AvenueDODoomers Media LLC+4 more

Verdant Robotics builds the SharpShooter, a precision agriculture system that uses machine vision to detect individual plants and apply targeted micro-shots of herbicide or other inputs, replacing broadcast spraying, manual weeding, and thinning.

AgTechAI & Machine LearningRoboticsHayward, US

GSGabe Sibley(Founder)inCGCurtis Garner(Founder)inLILawrence Ibarria(Founder)inDavid(Technology leader)inGabe Sibley Curtis Garner(Founder)

BoardKSKiersten Stead(Director)in

Co-investorsATATEL VenturesCACavallo VenturesCLCleveland AvenueDCDCVC (Data Collective)DODoon CapitalFUFuture Ventures+4 more